ArticleMolecular neurobiology2025
EP300 Regulates CD8br AC (TBNK Panel) to Facilitate Insomnia.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insomnia is a prevalent clinical condition that is caused by the interaction of environmental, inflammatory, immune system, physiological, and psychological factors. Nevertheless, the significance of lactylation-related gene in the pathogenesis of insomnia remains unknown. The causal relationship between lactylation-related gene and insomnia was initially analyzed using Mendelian randomization. Exposure was determined using cis-expression quantitative trait loci (cis-eQTL) from the Expression Quantitative Trait Locus Gen (eQTLGen) consortium. We obtained insomnia from the FinnGen database, which comprises 490,763 controls and 6776 cases. Subsequently, we performed a difference analysis of the Gene Expression Omnibus (Geo) data on insomnia and a summary-data-based MR (SMR) analysis to further validate our findings. We used a mediation approach by immune cells to study the effect of lactylation-related genes on insomnia. We identified one lactylation-related gene associated with insomnia. EP300 also passed the SMR test (p < 0.05), and heterogeneity was assessed using the auxiliary heterogeneity in dependent instruments (HEIDI) test (p > 0.05). Using data from the Geo database, the overall difference in EP300 expression between insomnia patients and healthy individuals was compared and found to be significant. A mediation analysis was employed to investigate the impact of immune cells and EP300 on insomnia. We found that EP300 may promote insomnia by regulating the CD8br AC (TBNK panel). This provides new insights into the relationship between lactylation-related genes and insomnia and serves as a novel therapeutic target for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.